0000950123-11-053545.txt : 20110524 0000950123-11-053545.hdr.sgml : 20110524 20110524164426 ACCESSION NUMBER: 0000950123-11-053545 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110522 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20110524 DATE AS OF CHANGE: 20110524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REVA Medical, Inc. CENTRAL INDEX KEY: 0001496268 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 330810505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54192 FILM NUMBER: 11868479 BUSINESS ADDRESS: STREET 1: 5751 COPLEY DRIVE, SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92111 BUSINESS PHONE: (858) 966-3000 MAIL ADDRESS: STREET 1: 5751 COPLEY DRIVE, SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92111 8-K 1 a59593e8vk.htm FORM 8-K e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 22, 2011
REVA MEDICAL, INC.
(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction
of incorporation) 		  000-54192
(Commission
File Number) 		  33-0810505
(I.R.S. Employer
Identification No.)
     
5751 Copley Drive, Suite B    
San Diego, CA
(Address of principal executive offices) 		  92111
(Zip Code)
(858) 966-3000
(Registrant’s telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 5.07   Submission of matters to a Vote of Security Holders.
The following matters were voted upon at the Annual Meeting of Stockholders of REVA Medical, Inc. (the “Company”), held on 23 May 2011, at 10:30 a.m., Australian Eastern Standard Time (which is 5:30 p.m. on May 22, 2011 U.S. Pacific Daylight Time):
1.   To elect two members of the Board. The stockholders elected two Class I directors to hold office until the 2014 Annual Meeting of Stockholders, or until their successors are duly elected and qualified or until their earlier death, resignation or removal, by the following votes:
                         
                    Broker  
Name of Directors Elected   For     Withhold     Non-Votes  
Brian H. Dovey
     25,264,584       0       0  
Anne Keating
     25,264,584       0       0  
The following individuals are continuing directors with terms expiring upon the 2012 Annual Meeting of Stockholders: Gordon E. Nye and Robert Thomas.
The following individuals are continuing directors with terms expiring upon the 2013 Annual Meeting of Stockholders: Robert B. Stockman and James J. Schiro.
2.   To ratify the appointment of Ernst & Young LLP to serve as the independent registered public accountant for the 2011 fiscal year. The proposal was approved by the following vote:
         
For   Against   Abstain
25,264,584
  0   0
3.   To vote on an advisory (non-binding) basis on the compensation of our named executive officers. The proposal was approved by the following vote:
             
For   Against   Abstain   Broker Non-Votes
25,264,584   0   0   0
4.   To vote on an advisory (non-binding) basis on the frequency of an advisory vote on executive compensation in the future. The vote of every One Year received the largest number of votes, as indicated below:
                 
                Broker
One Year   Two Years   Three Years   Abstain   Non-Votes
23,346,910   0   1,647,406   270,268   0
Based on these voting results, the Company’s board of directors determined to hold an advisory vote on the compensation of its named executive officers every year until the next stockholder vote on the frequency of stockholder votes on the compensation of the Company’s named executive officers. A stockholder vote on the frequency of stockholder votes on the compensation of named executive officers is required to be held at least once every six years.

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  REVA Medical, Inc.
 		  
Date: May 24, 2011  /s/ Katrina Thompson    
  Katrina Thompson   
  Chief Financial Officer
(principal financial and accounting officer)